53 results
8-K
EX-99.1
LAB
Standard BioTools Inc
8 May 24
Standard BioTools Reports First Quarter 2024 Financial Results
4:31pm
Depreciation and amortization
Gain/loss on disposal of property and equipment
Non-GAAP operating expenses
R&D operating expenses
Stock-based … compensation expense
Depreciation and amortization
Non-GAAP R&D operating expenses
SG&A operating expenses
Stock-based compensation expense
Amortization
8-K
EX-99.1
LAB
Standard BioTools Inc
25 Apr 24
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
8:06am
, general and administrative (SG&A) expenses, the closure of the Company’s R&D facility in San Diego, as well as savings related to a more prioritized R&D strategy
8-K
EX-99.1
LAB
Standard BioTools Inc
28 Feb 24
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
Non-GAAP operating expenses
GAAP R&D operating expenses
Stock-based compensation expense
Depreciation and amortization
Impairment of intangible assets …
Non-GAAP R&D operating expenses
GAAP SG&A operating expenses
Stock-based compensation expense
Depreciation and amortization
Loss on disposal
8-K
EX-99.2
uuegjuh4esgc4gjtj3y
8 Jan 24
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
8:39am
425
EX-99.1
9rzt1zx e5d
19 Dec 23
Business combination disclosure
4:47pm
8-K
EX-99.1
yp6 fn28hu7
19 Dec 23
Investor Presentation Unlocking Value in a Fragmented Space DECEMBER 2023
4:45pm
424B3
5w2ci1v3b462r oddwx
1 Dec 23
Prospectus supplement
4:33pm
S-4/A
4twpyoc
30 Nov 23
Registration of securities issued in business combination transactions (amended)
9:13pm
425
EX-99.1
4np8aqo738hw osj0
28 Nov 23
Business combination disclosure
9:11pm
8-K
EX-99.1
v1lob
28 Nov 23
Standard BioTools Activating Strategy to Become a Diversified Leader in Life Sciences Tools NOVEMBER 2023
9:09pm
S-4
5kkwp 24xv
13 Nov 23
Registration of securities issued in business combination transactions
9:35pm
8-K
EX-99.1
263nw
7 Nov 23
Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results
4:07pm
425
oxzp2w13
4 Oct 23
Business combination disclosure
4:30pm
425
vqs32v6zc7 ikd26mt
4 Oct 23
Business combination disclosure
4:30pm
425
x2mp 1vb6s1g69hwxi
4 Oct 23
Business combination disclosure
4:29pm
425
EX-99.2
qhjm3ftgu5ekt
4 Oct 23
Business combination disclosure
8:13am
8-K
EX-99.2
lw06szy
4 Oct 23
Standard BioTools and SomaLogic to Combine in All-Stock Merger
8:08am